<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941117-2-00044</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  November 28, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=4 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=4 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=4 -->  <RINDOCK>[Docket No. 94N&hyph;0219]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=4 -->  Lemmon Co., et al.; Withdrawal of Approval of NADA's <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Notice. <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is withdrawing approval of three new animal drug applications (NADA's) held by Lemmon Co., Banner Pharmacaps, Inc., and Nutra-Blend Corp. The sponsors requested the withdrawals of approval. In a final rule published elsewhere in this issue of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> , FDA is amending the regulations by removing the entries which reflect approval of the NADA's. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  November 28, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Mohammad I. Sharar, Center for Veterinary Medicine (HFV&hyph;216), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;0749. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  FDA is withdrawing approval of three NADA's on the written request of the following sponsors: Lemmon Co., 650 Cathill Rd., Sellersville, PA 18960, is the sponsor of NADA 65&hyph;467 that provides for the use of Tetracycline Hydrochloride Capsules in dogs for the treatment of bacterial gastroenteritis and urinary tract infections. Lemmon Co. requested, in its letter of May 2, 1994, that FDA withdraw approval of NADA 65&hyph;467 because the firm no longer manufactures or markets the product. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Banner Pharmacaps, Inc. (formerly Pharmacaps, Inc.), P.O. Box 547, 1111 Jefferson Ave., Elizabeth, NJ 07207, is the sponsor of NADA 119&hyph;844 that provides for the use of Dichlorophene/Toluene Capsules in dogs and cats as an anthelmintic. Banner Pharmacaps, Inc., requested, in its letter of April 20, 1994, that FDA withdraw approval of NADA 119&hyph;844 because the firm no longer manufactures or markets the product. <!-- PJG 0012 frnewline -->  Nutra-Blend Corp., Rt. 7, Box 192A, Neosho, MO 64850, is the sponsor of NADA 129&hyph;160 that provides for the manufacture of a Type B medicated feed containing 0.6 gram of hygromycin B per pound. This approved NADA is not required for the firm to manufacture a Type B medicated feed containing 0.6 gram of hygromycin B per pound. Accordingly, in a letter dated March 18, 1994, the firm requested that FDA withdraw the approval for NADA 129&hyph;160. <!-- PJG 0012 frnewline -->   Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10) and redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with &sect;514.115  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Withdrawal of approval of applications <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (21 CFR 514.115), notice is given that approval of NADA's 65&hyph;467, 119&hyph;844, and 129&hyph;160, and all supplements and amendments thereto is hereby withdrawn, effective November 28, 1994. <!-- PJG 0012 frnewline -->   In a final rule published elsewhere in this issue of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , FDA is amending 21 CFR 520.2345a, 21 CFR 520.580, 21 CFR 510.600(c)(1) and (c)(2), and 21 CFR 558.274 to reflect the withdrawal of approval of these NADA's. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: November 8, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Stephen F. Sundlof, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, Center for Veterinary Medicine. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;28332 Filed 11&hyph;16&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            